Ocugen Statistics
NASDAQ: OCGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.00-0.04 (-3.85%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Ocugen by the numbers
Ocugen has a market capitalization of $339.1 million based on 339.11M shares outstanding. With trailing EPS of $-0.26, Ocugen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.4% below its 50-day average and 32.9% below its 200-day average.
Average daily trading volume is 5.84M shares, or about $5.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCGN valuation vs. peer median
| Metric | OCGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $339.11M | $344.58M | -2% |
| Avg. volume | 5.84M | 1.15M | +407% |
Peer median across 8 companies: CCCC, ARTV, FENC, AGEN, CABA, SCTX, KYTX, ZURA.
Valuation
- Market cap
- $339.11M
- EPS (TTM)
- $-0.26
- Shares outstanding
- 339.11M
Price and trading
- Previous close
- 1.04
- Open
- 1.04
- Day range
- 1.00 – 1.05
- 52-week range
- 0.97 – 2.73
- 52-week change
- -43.18%
- Beta
- —
- Volume
- 5.20M
- Average volume
- 5.84M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 339.11M
- Forward Pe
- -3.95
- Eps
- -0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.73
- Week52 Low
- 0.97
- Avg Volume
- 5.84M
- Shares Outstanding
- 339.11M
- Ma50
- 1.21
- Ma200
- 1.49
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -63.30%
- Pct From52w Low
- 3.09%